Literature DB >> 32439021

Neurodevelopmental Factors in Schizophrenia.

Hanna Jaaro-Peled1, Akira Sawa2.   

Abstract

The onset of schizophrenia is usually in late adolescence or early adulthood. However, accumulating evidence has suggested that the disease condition is an outcome of gene-environment interactions that act in neural development during early life and adolescence. Some children who later develop schizophrenia have early developmental and educational and social challenges. Some patients with schizophrenia have an abundance of nonspecific neurologic soft signs and minor physical anomalies. Adolescence is a sensitive period of increased neuronal plasticity. It is important to consider early detection and intervention from the prodromal stage to early disease to prevent its devastating long-term consequences.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early intervention; Gene-environment; Neurodevelopment; Schizophrenia

Mesh:

Year:  2020        PMID: 32439021     DOI: 10.1016/j.psc.2020.02.010

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  7 in total

Review 1.  Pathophysiology of cognitive dysfunction and the role of combined brain/heart magnetic resonance imaging (Review).

Authors:  George Markousis-Mavrogenis; Flora Bacopoulou; Genovefa Kolovou; Maria-Roser Pons; Aikaterini Giannakopoulou; Antigoni Papavasiliou; George D Kitas; George P Chrousos; Sophie I Mavrogeni
Journal:  Exp Ther Med       Date:  2022-07-14       Impact factor: 2.751

2.  Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe.

Authors:  Christoph U Correll; Paolo Fusar-Poli; Stefan Leucht; Anne Karow; Nadja Maric; Carmen Moreno; Merete Nordentoft; Andrea Raballo
Journal:  Neuropsychiatr Dis Treat       Date:  2022-02-09       Impact factor: 2.570

3.  Association of NKAPL rs1635 With Cognitive Function in Early-Onset Schizophrenia.

Authors:  Yang Yang; Yi Su; Guiming Wei; Zhewei Kang; Zhe Lu; Yundan Liao; Tianlan Lu; Hao Yan; Weihua Yue; Ying Qin; Yuyanan Zhang
Journal:  Front Genet       Date:  2022-06-21       Impact factor: 4.772

Review 4.  It takes two to tango: Widening our understanding of the onset of schizophrenia from a neuro-angiogenic perspective.

Authors:  Bárbara S Casas; David Arancibia-Altamirano; Franco Acevedo-La Rosa; Delia Garrido-Jara; Vera Maksaev; Dan Pérez-Monje; Verónica Palma
Journal:  Front Cell Dev Biol       Date:  2022-08-24

5.  Comparative Study of the Effects of Atypical Antipsychotic Drugs on Plasma and Urine Biomarkers of Oxidative Stress in Schizophrenic Patients.

Authors:  Anna Dietrich-Muszalska; Joanna Kolodziejczyk-Czepas; Pawel Nowak
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-17       Impact factor: 2.570

Review 6.  Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia.

Authors:  Katarzyna Chamera; Magdalena Szuster-Głuszczak; Agnieszka Basta-Kaim
Journal:  Pharmacol Rep       Date:  2021-05-22       Impact factor: 3.024

Review 7.  Gene-Environment Interactions in Schizophrenia: A Literature Review.

Authors:  Marah H Wahbeh; Dimitrios Avramopoulos
Journal:  Genes (Basel)       Date:  2021-11-23       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.